This facility is dedicated to manufacturing Cephalosporins and its combination products. It has the capacity to manufacture Solid and Liquid dosage forms of Cephalosporins.
This facility houses a State-of-the-Art Pilot Plant for the manufacture of exhibit batches for Regulated Markets. This facility is approved by US-FDA and WHO-GMP. Currently caters to the needs of the Indian market.
Triple Shift Basis
Oral Liquid -Bottles / per month
Solid Dosage -Tablets / per month
Solid Dosage -Dry Syrup Powder (Bottles) / per month
|Dry Syrup Powders